ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Hydrochloric Acid → N-[3-methyl-N-(2,2-diphenylacetyl)-L-phenylalanyl]-S-trityl-L-cysteinamide

HRID 276727
ノート
印刷プレビュー

反応式

HRID 276727 の反応式
COC(C1C=C(COC[C@@H:14]([NH:17][C:18](=[O:44])[C@H:19]([CH2:36][C:37]2[CH:42]=[CH:41][CH:40]=[C:39]([CH3:43])[CH:38]=2)[NH:20][C:21](=[O:35])[CH:22]([C:29]2[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=2)[C:23]2[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=2)[C:15]#[N:16])C=CC=1)=O.O.[OH:46]N1C2C=CC=CC=2N=N1.CN1CCOCC1.CN(C)CCCN=C=NCC.Cl.[C:75]([S:94][CH2:95][C@@H](C(N)=O)N)([C:88]1[CH:93]=[CH:92][CH:91]=[CH:90][CH:89]=1)([C:82]1[CH:87]=[CH:86][CH:85]=[CH:84][CH:83]=1)[C:76]1[CH:81]=[CH:80][CH:79]=[CH:78][CH:77]=1>C(Cl)Cl>[CH3:43][C:39]1[CH:38]=[C:37]([CH:42]=[CH:41][CH:40]=1)[CH2:36][C@@H:19]([C:18]([NH:17][C:14](=[O:46])[C@H:15]([CH2:95][S:94][C:75]([C:76]1[CH:81]=[CH:80][CH:79]=[CH:78][CH:77]=1)([C:88]1[CH:89]=[CH:90][CH:91]=[CH:92][CH:93]=1)[C:82]1[CH:83]=[CH:84][CH:85]=[CH:86][CH:87]=1)[NH2:16])=[O:44])[NH:20][C:21](=[O:35])[CH:22]([C:29]1[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=1)[C:23]1[CH:24]=[CH:25][CH:26]=[CH:27][CH:28]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 6

HCID 313Hydrochloric AcidHCID 79724-MethylmorpholineHCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 27960291-Hydroxybenzotriazole hydrateHCID 44432703(2R)-2-amino-3-((triphenylmethyl)sulfanyl)propanamideHCID 86608564N-[2-[(3-(methoxycarbonyl)phenyl)methoxy]-1(S)-cyanoethyl]-3-methyl-Nalpha-(2,2-diphenylacetyl)-L-phenylalaninamide

生成物 1

HCID 69266013N-[3-methyl-N-(2,2-diphenylacetyl)-L-phenylalanyl]-S-trityl-L-cysteinamide

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

実験手順

To a solution of 3-methyl-N-(2,2-diphenylacetyl-L-phenylalanine (see example 302, 1.0 g, 2.68 mmol), 1-hydroxybenzotriazole hydrate (0.41 g, 2.68 mmol) and N-methylmorpholine (0.74 mL, 6.69 mmol) in CH2Cl2 (80 mL) is added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide.HCl (0.77 g, 4.02 mmol) in one portion. After stirring 30 minutes at room temperature, S-trityl-L-cysteinamide (0.97 g, 2.68 mmol) is added to the solution in one portion, and the solution is stirred for 16 hours. The solution is evaporated, and the residue partitioned between water (80 mL) and ethyl acetate (80 mL). The aqueous layer is washed with EtOAc (2×80 mL), and the combined organic layers are then washed with 1 N HCl (100 mL), saturated aqueous NaHCO3 (1×50 mL), water (1×50 mL) and brine (1×50 mL), dried over MgSO4, and evaporated. The residue is triturated with Et2O/hexane (1:1) to yield N-[3-methyl-N-(2,2-diphenylacetyl)-L-phenylalanyl]-S-trityl-L-cysteinamide as a white solid.

後処理

  1. stirringthe solution is stirred for 16 hours
  2. customThe solution is evaporated
  3. customthe residue partitioned between water (80 mL) and ethyl acetate (80 mL)
  4. washThe aqueous layer is washed with EtOAc (2×80 mL)
  5. washthe combined organic layers are then washed with 1 N HCl (100 mL), saturated aqueous NaHCO3 (1×50 mL), water (1×50 mL) and brine (1×50 mL)
  6. dry with materialdried over MgSO4
  7. customevaporated
  8. customThe residue is triturated with Et2O/hexane (1:1)

出典と根拠

ORDレコード
ord-507de8f9dbad465ca60d6a9eda7c5cbc
出典データセット
uspto-grants-2002_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06353017B1

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート